🇺🇸 FDA
Patent

US 9271960

Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control

granted A61KA61K31/343A61K31/403

Quick answer

US patent 9271960 (Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control) held by PTC THERAPEUTICS, INC. expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/343, A61K31/403, A61K31/4035, A61K31/407